SCHEMBL21200369

SCHEMBL21200369

Cn1c(S)nnc1C(F)(F)C(C)(O)c1cccc(NC(=O)O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ ACSS2 Q9NR19 1/20 0.39
▸ CBLB Q13191 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ GAA P10253 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ MAPK1 P28482 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KCNJ6 P48051 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28940818 0.88 RXFP1 (0.45) AKR1C3ACSS2CBLBTSHRALDH1A1
SCHEMBL29626649 0.88 RXFP1 (0.45) AKR1C3ACSS2CBLBTSHRALDH1A1
SCHEMBL21201152 0.81 CBLB (0.55) AKR1C3MEN1KMT2AMAPTHTT
SCHEMBL28741805 0.77 MEN1 (0.40) MEN1KMT2AMAPTCBLBLMNA
SCHEMBL21200967 0.75 MEN1 (0.35) AKR1C3MEN1KMT2AHTTRAB9A
SCHEMBL21201375 0.71 — —
SCHEMBL17925886 0.71 MEN1 (0.57) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL21200198 0.71 CBLB (0.66) AKR1C3MAPTCBLB
Ammonia Solution, Strong SCHEMBL28873301 0.70 MAPT (0.55) MEN1KMT2AMAPTHTTRAB9A
SCHEMBL23213561 0.70 MEN1 (0.50) MEN1KMT2AMAPTHTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003965-A1 UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION Nurix Therapeutics, Inc. (US) 2022-06-01 — — EP disclosed
WO-2021021761-A1 UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION NURIX THERAPEUTICS, INC. (US) 2021-02-04 — — WO disclosed
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback